Literature DB >> 26482872

Feasibility of asymmetrical flow field-flow fractionation as a method for detecting protective antigen by direct recognition of size-increased target-captured nanoprobes.

Kayeong Shin1, Jaeyeong Choi2, Jun-Haeng Cho1, Moon-Young Yoon1, Seungho Lee3, Hoeil Chung4.   

Abstract

Asymmetrical flow field-flow fractionation (AF4) was evaluated as a potential analytical method for detection of a protective antigen (PA), an Anthrax biomarker. The scheme was based on the recognition of altered AF4 retention through the generation of the size-increased Au nanoparticle probes as a result of PA binding, in which a PA-selective peptide was conjugated on the probe surface. In the visible absorption-based AF4 fractograms, the band position shifted to a longer retention time as the PA concentration increased due to the presence of probe bound with PAs. The shift was insignificant when the concentration was relatively low at 84.3pM. To improve sensitivity, two separate probes conjugated with two different peptides able to bind on different PA epitopes were used together. The band shift then became distinguishable even at 84.3pM of PA sample. The formation of larger PA-probe inter-connected species using the dual-probe system was responsible for the enhanced band shift. In parallel, the feasibility of surface-enhanced Raman scattering (SERS) as a potential AF4 detection method was also evaluated. In the off-line SERS fractogram constructed using fractions collected during AF4 separation, a band shift was also observed for the 84.3pM PA sample, and the band intensity was higher when using the dual-probe system. The combination of AF4 and SERS is promising for the detection of PA and will become a potential tool if the reproducibility of SERS measurement is improved.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anthrax; Asymmetrical flow field-flow fractionation (AF4); Protective antigen (PA); Surface-enhanced Raman scattering (SERS)

Mesh:

Substances:

Year:  2015        PMID: 26482872     DOI: 10.1016/j.chroma.2015.09.089

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  1 in total

1.  Proteins and antibodies in serum, plasma, and whole blood-size characterization using asymmetrical flow field-flow fractionation (AF4).

Authors:  Mats Leeman; Jaeyeong Choi; Sebastian Hansson; Matilda Ulmius Storm; Lars Nilsson
Journal:  Anal Bioanal Chem       Date:  2018-05-29       Impact factor: 4.142

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.